GMP 세포은행 서비스 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Persistence Market Research has recently released a detailed report on the global GMP (Good Manufacturing Practice) Cell Banking Service Market. The report provides an in-depth analysis of crucial market dynamics, such as key growth drivers, trends, opportunities, and challenges, offering valuable insights into the market's structure. This research publication outlines key data and statistics forecasting the growth of the GMP cell banking service market from 2024 to 2031.

Key Insights:

• GMP Cell Banking Service Market Size (2024E): US$ 967.4 Mn
• Projected Market Value (2031F): US$ 2,275.9 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 13.0%

GMP Cell Banking Service Market - Report Scope:

GMP cell banking services are vital for ensuring the production of biologics and other pharmaceutical products that require high-quality, safe, and compliant cell lines. These services involve the creation and storage of cell banks used for the production of cell-based therapies and vaccines. The GMP cell banking market is driven by the increasing demand for biopharmaceuticals, the rise in cell-based therapies, and growing regulatory requirements around the manufacturing process of biologics. Companies are investing in state-of-the-art facilities to develop and maintain GMP-compliant cell lines, which meet the highest standards of safety and efficacy. Additionally, the growing demand for personalized medicine and regenerative therapies continues to propel the market.

Market Growth Drivers:

The global GMP cell banking service market is primarily driven by the growing demand for biologics and cell-based therapies. The rapid advancements in regenerative medicine, coupled with the rising prevalence of chronic diseases, are pushing the need for quality-controlled cell lines. Increasing investments in biopharmaceutical R&D and the rising demand for personalized medicine also support market expansion. Regulatory authorities, such as the FDA and EMA, emphasize stringent compliance with GMP standards, ensuring the safety and efficacy of cell-based therapeutics. Additionally, the shift towards advanced therapies such as CAR-T cells is creating opportunities for GMP cell banking services.

Market Restraints:

Despite its robust growth, the GMP cell banking service market faces challenges such as high operational costs associated with maintaining GMP-compliant facilities and adhering to stringent regulatory standards. Moreover, the complexity of developing and storing cell lines that meet the required specifications can delay product timelines. Another challenge is the potential risk of contamination during the cell banking process, which could jeopardize the quality and safety of the final product. These factors may limit market growth in certain regions.

Market Opportunities:

The GMP cell banking service market offers significant growth opportunities, especially with the increasing focus on personalized medicine and the development of novel cell-based therapies. The introduction of automated systems in cell banking processes offers an opportunity to reduce human error, improve efficiency, and lower operational costs. Expanding research and clinical trials into new cell-based therapies like gene editing and immunotherapy presents new avenues for growth. Additionally, strategic partnerships between biotech firms and contract manufacturing organizations (CMOs) could enable faster, more cost-effective cell line development and commercialization.

Key Questions Answered in the Report:

• What are the primary drivers contributing to the growth of the GMP cell banking service market globally?
• Which regions are witnessing the highest demand for GMP-compliant cell lines and why?
• How are technological innovations, such as automation and cryopreservation techniques, shaping the future of the GMP cell banking market?
• Who are the leading players in the GMP cell banking service market, and what strategies are they using to maintain a competitive edge?
• What are the emerging trends in the GMP cell banking service sector, and how are they expected to impact market dynamics?

Competitive Intelligence and Business Strategy:

Leading companies in the GMP cell banking service market, such as Lonza, WuXi AppTec, and Catalent, are focusing on enhancing their service offerings through innovation, geographic expansion, and strategic collaborations. These firms are investing heavily in research and development to provide advanced cell banking solutions, including optimized storage techniques and cutting-edge automation for improved operational efficiency. Key players are also establishing new facilities in strategic regions to capture growing demand in emerging markets. Sustainability initiatives and technology adoption remain central to their business strategies to stay competitive in the evolving landscape of GMP cell banking services.

Key Companies Profiled:

• WuXi AppTec
• Charles River Laboratories International, Inc.
• Eurofins Scientific
• Merck KGaA
• Lonza Group Ltd
• SGS Ltd
• ViruSure GmbH
• Austrianova
• Goodwin Biotechnology Inc.
• Paragon Bioservices, Inc.

Market Segmentation

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• MEA

By Cell Type

• Mammalian
• Microbial
• Insect
• Yeast
• Avian
• Stem Cell

By End User

• Biopharmaceutical Companies
• Contract Manufacturing Organizations

Table of Contents

1. Executive Summary

2. GMP Cell Banking Services Market Introduction

• 2.1. GMP Cell Banking Services Market Introduction and Definitions
• 2.2. GMP Cell Banking Services Market Taxonomy

3. GMP Cell Banking Services Market Analysis Scenario

• 3.1. Market Scenario (US$ Mn) Forecast
• 3.2. Market Size (US$ Mn) and Forecast
  • 3.2.1. Market Value (US$ Mn) and Y-o-Y Growth
  • 3.2.2. Absolute $ Opportunity
• 3.3. Cell Banking: Process Workflow
• 3.4. Regulatory Overview: U.S. FDA Guidance on Contract Manufacturing

4. GMP Cell Banking Services Market Dynamics

• 4.1. Macro-economic Drivers
• 4.2. Drivers
  • 4.2.1. Supply-side
  • 4.2.2. Demand-side
• 4.3. Restraints
• 4.4. Opportunities
• 4.5. Trends

5. Global GMP Cell Banking Services Market By Cell Type

• 5.1. GMP Cell Banking Services Market Share Analysis and Y-o-Y Analysis By Cell Type, 2024-2031
• 5.2. GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 5.2.1. Mammalian Cell Type
  • 5.2.2. Microbial Cell Type
  • 5.2.3. Insect Cell Type
  • 5.2.4. Yeast Cell Type
  • 5.2.5. Avian Cell Type
  • 5.2.6. Stem Cell Type
  • 5.2.7. Other Cell Type
• 5.3. GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
• 5.4. GMP Cell Banking Services Market Attractiveness Analysis By Cell Type, 2024-2031

6. Global GMP Cell Banking Services Market By End User

• 6.1. GMP Cell Banking Services Market Share Analysis and Y-o-Y Analysis By End User, 2024-2031
• 6.2. GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 6.2.1. Biopharmaceutical Companies
  • 6.2.2. Contract Manufacturing Organizations
• 6.3. GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
• 6.4. GMP Cell Banking Services Market Attractiveness Analysis By End User, 2024-2031

7. Global GMP Cell Banking Services Market By Region

• 7.1. GMP Cell Banking Services Market Share Analysis and Y-o-Y Analysis By Region, 2024-2031
• 7.2. GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
  • 7.2.1. North America
  • 7.2.2. Latin America
  • 7.2.3. Europe
  • 7.2.4. Asia Pacific
  • 7.2.5. Middle East & Africa
• 7.3. GMP Cell Banking Services Market Value Analysis and Forecast By Region, 2024-2031
• 7.4. GMP Cell Banking Services Market Attractiveness Analysis By Region, 2024-2031

8. North America GMP Cell Banking Services Market Analysis

• 8.1. North America GMP Cell Banking Services Market Share Analysis and Y-o-Y Growth Analysis By Country, 2024-2031
• 8.2. U.S. GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 8.3. Canada GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 8.4. North America GMP Cell Banking Services Market Value Analysis and Forecast By Country, 2024-2031
  • 8.4.1. U.S.
  • 8.4.2. Canada
• 8.5. North America GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
  • 8.5.1. Mammalian Cell Type
  • 8.5.2. Microbial Cell Type
  • 8.5.3. Insect Cell Type
  • 8.5.4. Yeast Cell Type
  • 8.5.5. Avian Cell Type
  • 8.5.6. Stem Cell Type
  • 8.5.7. Other Cell Type
• 8.6. North America GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
  • 8.6.1. Biopharmaceutical Companies
  • 8.6.2. Contract Manufacturing Organizations
• 8.7. North America GMP Cell Banking Services Market Attractiveness Analysis, 2024-2031
  • 8.7.1.By Country
  • 8.7.2.By Cell Type
  • 8.7.3.By End User
• 8.8. North America: Drivers and Restraints Impact Analysis

9. Latin America GMP Cell Banking Services Market Analysis

• 9.1. Latin America GMP Cell Banking Services Market Share Analysis and Y-o-Y Growth Analysis By Country, 2024-2031
• 9.2. Brazil GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 9.3. Mexico GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 9.4. Rest of Latin America GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 9.5. Latin America GMP Cell Banking Services Market Value Analysis and Forecast By Country, 2024-2031
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America
• 9.6. Latin America GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
  • 9.6.1. Mammalian Cell Type
  • 9.6.2. Microbial Cell Type
  • 9.6.3. Insect Cell Type
  • 9.6.4. Yeast Cell Type
  • 9.6.5. Avian Cell Type
  • 9.6.6. Stem Cell Type
  • 9.6.7. Other Cell Type
• 9.7. Latin America GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
  • 9.7.1. Biopharmaceutical Companies
  • 9.7.2. Contract Manufacturing Organizations
• 9.8. Latin America GMP Cell Banking Services Market Attractiveness Analysis, 2024-2031
  • 9.8.1. By Country
  • 9.8.2. By Cell Type
  • 9.8.3. By End User
• 9.9. Latin America: Drivers and Restraints Impact Analysis

10. Europe GMP Cell Banking Services Market Analysis

• 10.1. Europe GMP Cell Banking Services Market Share Analysis and Y-o-Y Growth Analysis By Country, 2024-2031
• 10.2. U.K. GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 10.3. France GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 10.4. Germany GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 10.5. Italy GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 10.6. Spain GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 10.7. Russia GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 10.8. Rest of Europe GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 10.9. Europe GMP Cell Banking Services Market Value Analysis and Forecast By Country, 2024-2031
  • 10.9.1. U.K.
  • 10.9.2. France
  • 10.9.3. Germany
  • 10.9.4. Italy
  • 10.9.5. Spain
  • 10.9.6. Russia
  • 10.9.7. Rest of Europe
• 10.10. Europe GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
  • 10.10.1. Mammalian Cell Type
  • 10.10.2. Microbial Cell Type
  • 10.10.3. Insect Cell Type
  • 10.10.4. Yeast Cell Type
  • 10.10.5. Avian Cell Type
  • 10.10.6. Stem Cell Type
  • 10.10.7. Other Cell Type
• 10.11. Europe GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
  • 10.11.1. Biopharmaceutical Companies
  • 10.11.2. Contract Manufacturing Organizations
• 10.12. Europe GMP Cell Banking Services Market Attractiveness Analysis, 2024-2031
  • 10.12.1. By Country
  • 10.12.2. By Cell Type
  • 10.12.3. By End User
• 10.13. Europe: Drivers and Restraints Impact Analysis

11. Asia Pacific GMP Cell Banking Services Market Analysis

• 11.1. Asia Pacific GMP Cell Banking Services Market Share Analysis and Y-o-Y Growth Analysis By Country, 2024-2031
• 11.2. Japan GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 11.3. China GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 11.4. India GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 11.5. Australia & New Zealand GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 11.6. ASEAN GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 11.7. Rest of Asia Pacific GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 11.8. Asia Pacific GMP Cell Banking Services Market Value Analysis and Forecast By Country, 2024-2031
  • 11.8.1. Japan
  • 11.8.2. China
  • 11.8.3. India
  • 11.8.4. Australia & New Zealand
  • 11.8.5. ASEAN
  • 11.8.6. Rest of Asia Pacific
• 11.9. Asia Pacific GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
  • 11.9.1. Mammalian Cell Type
  • 11.9.2. Microbial Cell Type
  • 11.9.3. Insect Cell Type
  • 11.9.4. Yeast Cell Type
  • 11.9.5. Avian Cell Type
  • 11.9.6. Stem Cell Type
  • 11.9.7. Other Cell Type
• 11.10. Asia Pacific GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
  • 11.10.1. Biopharmaceutical Companies
  • 11.10.2. Contract Manufacturing Organizations
• 11.11. Asia Pacific GMP Cell Banking Services Market Attractiveness Analysis, 2024-2031
  • 11.11.1. By Country
  • 11.11.2. By Cell Type
  • 11.11.3. By End User
• 11.12. Asia Pacific: Drivers and Restraints Impact Analysis

12. Middle East & Africa GMP Cell Banking Services Market Analysis

• 12.1. Middle East & Africa GMP Cell Banking Services Market Share Analysis and Y-o-Y Growth Analysis By Country, 2024-2031
• 12.2. GCC Countries GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 12.3. South Africa GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 12.4. North Africa GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 12.5. Rest of MEA GMP Cell Banking Services Market Value, Y-o-Y Growth & Absolute $ Opportunity, 2024-2031
• 12.6. Middle East & Africa GMP Cell Banking Services Market Value Analysis and Forecast By Country, 2024-2031
  • 12.6.1. GCC Countries
  • 12.6.2. South Africa
  • 12.6.3. North Africa
  • 12.6.4. Rest of MEA
• 12.7. Middle East & Africa GMP Cell Banking Services Market Value Analysis and Forecast By Cell Type, 2024-2031
  • 12.7.1. Mammalian Cell Type
  • 12.7.2. Microbial Cell Type
  • 12.7.3. Insect Cell Type
  • 12.7.4. Yeast Cell Type
  • 12.7.5. Avian Cell Type
  • 12.7.6. Stem Cell Type
  • 12.7.7. Other Cell Type
• 12.8. Middle East & Africa GMP Cell Banking Services Market Value Analysis and Forecast By End User, 2024-2031
  • 12.8.1. Biopharmaceutical Companies
  • 12.8.2. Contract Manufacturing Organizations
• 12.9. Middle East & Africa GMP Cell Banking Services Market Attractiveness Analysis, 2024-2031
  • 12.9.1. By Country
  • 12.9.2. By Cell Type
  • 12.9.3. By End User
• 12.10. Middle East & Africa: Drivers and Restraints Impact Analysis

13. Competitive Landscape

• 13.1. Global GMP Cell Banking Services Market - Dashboard
• 13.2. Company Profiles (Overview, Key Ratios, Financials, SWOT, Strategy, Recent Developments)
  • 13.2.1. WuXi AppTec
  • 13.2.2. Charles River Laboratories International, Inc.
  • 13.2.3. Eurofins Scientific
  • 13.2.4. Merck KGaA
  • 13.2.5. Lonza Group Ltd
  • 13.2.6. SGS Ltd
  • 13.2.7. ViruSure GmbH
  • 13.2.8. Austrianova
  • 13.2.9. Goodwin Biotechnology Inc.
  • 13.2.10. Paragon Bioservices, Inc.

14. Assumptions and Acronyms Used

15. Research Methodology